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Abiotrophia defectiva endocarditis in a child – a case report
Abiotrophia defectiva kao uzročnik endokarditisa u djeteta – prikaz bolesnika
Abstract
We present a case of endocarditis due to Abiotrophia defectiva in a child, de-
veloped as a complication of a previously unrecognized patent ductus arterio-
sus (PDA). The patient was successfully treated with antimicrobial therapy 
and later underwent transcatheter closure of PDA. As the organism may not 
be isolated in routine culture media, and may present with atypical clinical 
symptoms, a high index of suspicion should be maintained in children with 
subacute symptoms even with no underlying heart disease. Even patients with 
early appropriate antibiotic therapy and rapid achievement of bacteriological 
clearance remain at high risk for embolic and immune-mediated complications 
and irreversible valvular damage. Our case highlights the importance of careful 
interpretation of serologic tests and the value of good physical examination 
(auscultation!) in order not to miss the diagnosis of congenital heart defects.
Sažetak
U radu prikazujemo slučaj djeteta s endokarditisom čiji je uzročnik Abiotrophia 
defectiva, a koji je nastao kao komplikacija prethodno neprepoznatog otvore-
nog Botallovog duktusa. Dijete je uspješno liječeno antimikrobnim lijekovima 
nakon čega je provedeno i transkatetersko zatvaranje srčane greške. S obzirom 
na to da se ovaj uzročnik teško izolira na rutinskim bakterijskim podlogama 
i može uzrokovati atipične simptome, potreban je poseban oprez čak i u one 
djece koja nemaju podležeću srčanu bolest, ali se klinički prezentiraju sa suba-
kutnim simptomima. Imunološke komplikacije, embolizacije i trajno oštećenje 
zalistaka često se javljaju čak i u onih bolesnika s pravovremeno započetim is-
pravnim antibiotskim liječenjem i kod kojih je brzo postignut terapijski učinak 
antibiotika. Također ističemo važnost pažljive interpretacije seroloških testova 
kao i kvalitetnog fizičkog pregleda (auskultacije!) zbog mogućnosti propušta-
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 The spectrum of childhood infective endocarditis 
(IE) has been changed during the past several decades, 
largely because of the declining incidence of rheumatic 
heart disease and the increasing success in the treatment 
of patients with congenital heart disease (CHD). Among 
children with underlying CHD, Streptococcus and Staph-
ylococcus spp are equally and the most frequently isolat-
ed pathogens, while in patients with structurally normal 
heart, Staphylococcus aureus causes approximately 50% 
of cases [1]. Abiotrophia defectiva is a form of nutritional-
ly variant Streptococci (NVS) and causes about 4% to 6% 
of all streptococcal endocarditis [2].
 We present a case of endocarditis due to Abiotrophia 
defectiva in a child, developed as a complication of a pre-
viously unrecognized patent ductus arteriosus (PDA).
Case report
 A 5.5-year-old, previously healthy girl, presented to 
her primary care pediatrician with several days history of 
high grade fever and fatigue. Due to suspected acute otitis 
media, empiric antibiotic therapy with cefixime was initi-
ated and fever resolved promptly after one day of treat-
ment. Soon after discontinuation of therapy she became 
subfebrile again and as her symptoms persisted for the 
next 2 weeks, she was examined in a regional hospital. 
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become the predominant underlying condition in children 
diagnosed with IE living in developed nations. In fact, an 
increase in the number of IE cases associated with CHD 
has been observed due to the fact that most patients with 
CHD survive much longer than several decades ago [1].
 The oral mucosa and tooth surfaces of children who are 
beyond infancy are populated by a variety of pathogenic 
and nonpathogenic bacteria, which are representative of 
hundreds of strains of aerobic and anaerobic species. A. 
defectiva is found under normal conditions in the oral 
cavity, gastrointestinal tract, and genitourinary system. It 
has been involved in ocular infections—endophthalmitis 
or keratitis, otitis and paranasal cavities infections, osteo-
articular infections, infections following arthroplasty, cer-
ebral and pancreatic abscesses and iatrogenic meningitis 
[2,3]. IE caused by this organism usually is subacute in 
presentation, as it was in our patient.
 A PDA that persists beyond one month of age is esti-
mated to occur in 0.3–4 per 1000 live births, and accounts 
for approximately 10% of all CHD. It has been estimated 
that one-third of adults with unrepaired, hemodynamical-
ly significant PDAs will die of heart failure, pulmonary 
hypertension, or endocarditis by the age of 40, and this 
figure rises to two-third by age 60. In the preantibiotic era, 
IE was the single most common cause of death in PDA 
patients (42–45% of deaths) [4]. Between 1939 and 1971, 
five case series were published characterizing the associ-
ation between IE and PDA. The majority of authors con-
cluded that IE is rare in patients with PDA, but that when 
it does occur, surgical PDA ligation should be performed 
[2-5].
 Abiotrophia defectiva endocarditis has been rarely re-
ported in children. Chang et al reviewed 13 cases of IE 
caused by NVS in children reported in English literature 
since 1971. Nine of these patients (69%) had underlying 
heart disease [2].
 In comparison to beta-hemolytic streptococci (BHS), 
NVS demonstrate different antimicrobial susceptibility. 
NVS susceptibility to penicillin (8% according to some 
studies), carbapenems, cephalosporins, daptomycin, or 
macrolides is not certain [5]. Nevertheless, the isolate 
from our patient had good antimicrobial susceptibility.
 Several studies in adults have reported high rates of 
complications in Abiotrophia endocarditis including bac-
teriological failure rate up to 40%, fatal congestive cardiac 
failure in 17–20% of them, and embolization occurred in 
up to 27% of cases. This has been attributed to difficulty 
in isolating this organism and high drug resistance rates 
[2,3,5]. In contrast, our patient achieved relatively rap-
id bacteriological clearance, good clinical outcome and 
no relapse in the 12 months follow-up period (to date). 
However, it must be noted that even in patients with early 
appropriate antibiotic therapy and rapid achievement of 
Laboratory check-up was done and due to positive CMV 
IgM (1.82) and negative IgG (0.32) antibody accompanied 
with hepatosplenomegaly on physical examination, acute 
CMV infection was diagnosed. Since fever persisted and her 
fatigue was worsening after almost 5 weeks of illness, she 
was diagnosed with fever of unknown origin and trans-
ferred to our institution for further diagnostic procedure. 
Laboratory results at that time revealed slightly elevated 
ESR of 30 mm/1h, CRP of 15 mg/L and normal leukocyte 
count with mild neutrophilia (70%, ANC 4900/mm3). Re-
peated CMV serology came completely negative. On phys-
ical examination at admission she was subfebrile (Tax 
37.5°C) and pale, but other vital signs were normal. A pan-
systolic murmur grade two of six (II/VI) was heard along 
the left sternal border and her liver and spleen were both 
palpable for 3 cm below the costal margin. Laboratory results 
showed normal ESR (10 mm/1h), slightly elevated CRP 
(14.2 mg/L), normal leukocyte count, slightly decreased 
haemoglobin level (103 g/L) and prothrombin time (0.65) 
accompanied with hypergammaglobulinemia (15.0 g/L). 
Autoimmunity markers (ANA, ANCA, dsDNA, RF, CCP) 
were all negative, as well as serology to B.henselae and 
B.quintana. Chest X-ray was normal, except mildly en-
larged heart shadow with prominent left heart contour. 
Abdominal ultrasound confirmed mild hepatosplenomeg-
aly (liver 8.5 cm, spleen 12 cm). Transthoracic echocardi-
ogram was preformed and showed opened PDA, 4 mm 
wide in diameter, with left to right flow (4 mm/s) restric-
tive on pulmonary end. Regurgitation was mild and there 
were no signs of pulmonary hypertension; right heart cham-
bers were only mildly enlarged. No intracardiac vegeta-
tions were seen. Three blood cultures were drawn during 
the first 48 hours of hospitalization and all yielded Abi-
otrophia defectiva. The isolate was found to be sensitive to 
penicillin, ampicillin, ceftriaxone, vancomycin and line-
zolide. Dual parenteral antimicrobial therapy consisting of 
ampicillin (300 mg/kg/day divided q6h) and gentamicin 
(7 mg/kg/day divided q8h) was initiated. After five days 
ampicillin was switched to ceftriaxon (100 mg/kg/day q12h) 
and gentamicin was continued. After 18 days, the paren-
teral therapy was switched to oral cefpodoxime-proxetil 
(10 mg/kg/day q12h) and the patient was discharged 
home. The cefpodoxime-proxetil therapy lasted for 4 weeks. 
The patient’s later clinical course was favourable. She be-
came afebrile within two days from antimicrobial therapy 
initiation, with gradual complete regression of hepatosple-
nomegaly and normalization of laboratory findings. All 
blood cultures taken under antimicrobial therapy remained 
sterile. After hospital discharge, sanation of two caries le-
sions was done. Cardiologist indicated transcatheter clo-
sure of PDA which was done after treatment completion.
Discussion
 Since the prevalence of rheumatic heart disease sig-
nificantly declined within the past two decades, CHD has 
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bacteriological clearance, these patients remained at high 
risk for embolic and immune-mediated complications and 
irreversible valvular damage.
 As the organism may not be isolated in routine culture 
media, and may present with atypical clinical symptoms, 
a high index of suspicion should be maintained in children 
with subacute symptoms even with no underlying heart 
disease. Our case highlights the importance of careful in-
terpretation of serologic tests, always in conjunction with 
clinical findings, in order not to miss proper diagnosis due 
to cross reactivity of serology. Also, even in the 21st cen-
tury, we point out the value of good physical examina-
tion (auscultation!) not to miss the diagnosis of congenital 
heart defects.
